| Year |
Citation |
Score |
| 2019 |
Sun CW, Wu LC, Wankhede M, Wang D, Thoerner J, Woody L, Sorg BS, Townes TM, Terman DS. Exogenous sickle erythrocytes combined with vascular disruption trigger disseminated tumor vaso-occlusion and lung tumor regression. Jci Insight. 4. PMID 30944254 DOI: 10.1172/Jci.Insight.125535 |
0.511 |
|
| 2018 |
Devadasan D, Sun CW, Westin ER, Wu LC, Pawlik KM, Townes TM, Goldman FD. Bmt Following Non-Myeloablative Treosulfan Conditioning is Curative in a Murine Model of Sickle Cell Disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29684562 DOI: 10.1016/J.Bbmt.2018.04.011 |
0.593 |
|
| 2017 |
Sun CW, Wu LC, Knopick PL, Bradley DS, Townes T, Terman DS. Sickle Cells Produce Functional Immune Modulators and Cytotoxics. American Journal of Hematology. PMID 28646491 DOI: 10.1002/Ajh.24836 |
0.618 |
|
| 2017 |
Giordano S, Zhao X, Chen YF, Litovsky SH, Hage FG, Townes TM, Sun CW, Wu LC, Oparil S, Xing D. Induced Pluripotent Stem Cell-Derived Endothelial Cells Overexpressing Interleukin-8 Receptors A/B and/or C-C Chemokine Receptors 2/5 Inhibit Vascular Injury Response. Stem Cells Translational Medicine. PMID 28233474 DOI: 10.1002/Sctm.16-0316 |
0.554 |
|
| 2016 |
Li C, Ding L, Sun CW, Wu LC, Zhou D, Pawlik KM, Khodadadi-Jamayran A, Westin E, Goldman FD, Townes TM. Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction. Scientific Reports. 6: 30422. PMID 27460639 DOI: 10.1038/Srep30422 |
0.61 |
|
| 2016 |
Sun CW, Willmon C, Wu LC, Knopick P, Thoerner J, Vile R, Townes TM, Terman DS. Sickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In Vivo. Frontiers in Oncology. 6: 166. PMID 27458571 DOI: 10.3389/Fonc.2016.00166 |
0.579 |
|
| 2016 |
Chen Y, Giordano S, Xing D, Hage F, Townes T, Sun C, Wu L, Wallcott G, Brott B, Oparil S. PS 04-23 NOVEL TARGETED ENDOTHELIAL CELL THERAPY FOR VASCULAR INJURY IN RODENT AND PORCINE MODELS Journal of Hypertension. 34: e139. DOI: 10.1097/01.Hjh.0000500257.80486.2F |
0.554 |
|
| 2011 |
Zhang Z, Jones A, Sun CW, Li C, Chang CW, Joo HY, Dai Q, Mysliwiec MR, Wu LC, Guo Y, Yang W, Liu K, Pawlik KM, Erdjument-Bromage H, Tempst P, et al. PRC2 complexes with JARID2, MTF2, and esPRC2p48 in ES cells to modulate ES cell pluripotency and somatic cell reprogramming. Stem Cells (Dayton, Ohio). 29: 229-40. PMID 21732481 DOI: 10.1002/Stem.578 |
0.616 |
|
| 2009 |
Huo Y, McConnell SC, Liu SR, Yang R, Zhang TT, Sun CW, Wu LC, Ryan TM. Humanized Mouse Model of Cooley's Anemia. The Journal of Biological Chemistry. 284: 4889-96. PMID 19098001 DOI: 10.1074/Jbc.M805681200 |
0.398 |
|
| 2008 |
Isbell TS, Sun CW, Wu LC, Teng X, Vitturi DA, Branch BG, Kevil CG, Peng N, Wyss JM, Ambalavanan N, Schwiebert L, Ren J, Pawlik KM, Renfrow MB, Patel RP, et al. SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation. Nature Medicine. 14: 773-7. PMID 18516054 DOI: 10.1038/Nm1771 |
0.567 |
|
| 2007 |
Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (New York, N.Y.). 318: 1920-3. PMID 18063756 DOI: 10.1126/Science.1152092 |
0.646 |
|
| 2006 |
Wu LC, Sun CW, Ryan TM, Pawlik KM, Ren J, Townes TM. Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood. 108: 1183-8. PMID 16638928 DOI: 10.1016/J.Bcmd.2006.10.134 |
0.636 |
|
| 2005 |
Huo Y, McConnell S, Sun C, Wu L, Ryan TM. Generation of a Novel Mouse Model of Cooley’s Anemia. Blood. 106: 3654-3654. DOI: 10.1182/Blood.V106.11.3654.3654 |
0.374 |
|
| 2004 |
Ryan TM, Sun C, Wu L, Ren J, Townes TM. Correction of β Thalassemia by Homologous Recombination in Embryonic Stem Cells. Blood. 104: 373-373. DOI: 10.1182/Blood.V104.11.373.373 |
0.616 |
|
| Show low-probability matches. |